+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | CXCL14 |
Expression | Recombinant |
Tested Applications | SDS-PAGE |
Host | E. coli |
Conjugation | Unconjugated |
Form | Lyophilized |
Purity | > 95% (SDS-PAGE and RP-HPLC) |
Reconstitution | It is recommended to reconstitute the lyophilized CXCL14 in sterile 18M-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. |
Storage | Store desiccated below -18 °C. Upon reconstitution CXCL14 should be stored at 4 °C between 2-7 days and for future use below -18 °C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | O95715 (UniProt, ExPASy) |
UniProt Secondary AC | B3KQU8, Q6UW97, Q86U69, Q9BTR1, Q9NS21 |
UniProt Entry Name | CXL14_HUMAN |
KEGG | hsa:9547 |
String | 9606.ENSP00000337065 |
Sequence | The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Lys-Cys-Lys-Cys. |
Biological Activity | The ED5 of CXCL14 as determined by its ability to induce calcium flux of prostaglandin E2 treated THP1 human acute monocytic leukemia cells was 1.-1. ng/ml. |
Availability | Shipped within 5-10 working days. |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |